Mirati Therapeutics Inc (NASDAQ:MRTX)

93.44
Delayed Data
As of Sep 20
 +1.44 / +1.57%
Today’s Change
28.50
Today|||52-Week Range
111.99
+120.27%
Year-to-Date
Amgen's KRAS Inhibitor Shows Response in Larger NSCLC Group
Sep 09 / Zacks.com - Paid Partner Content
4 Biotech Stocks With Big Catalysts in September
Sep 05 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close92.00
Today’s open91.69
Day’s range91.04 - 93.86
Volume1,094,057
Average volume (3 months)675,304
Market cap$3.7B
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)-14.58%
Earnings growth (this year)-57.78%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales101.40
Price/Book15.08

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+0.07+0.08%
MDCOMedicines Co+0.92+1.91%
----
GWPHGW Pharmaceuticals P...-5.99-4.44%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 14, 2019
EPS forecast (this quarter)-$1.25
Annual revenue (last year)$12.9M
Annual profit (last year)-$98.4M
Net profit margin-761.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles M. Baum
Chief Financial Officer &
Senior Vice President
Jamie A. Donadio
Corporate headquarters
San Diego, California

Forecasts